A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy

PURPOSE: The highest rates of gastric cancer occur in Eastern Asia. Fluoropyrimidine-based therapy is used initially in unresectable and metastatic disease, but no single standard of care exists following disease progression. Ixabepilone, an epothilone B analog, is a non-taxane microtubule-stabilizi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeul Hong, Muro, Kei, Yasui, Hirofumi, Chen, Jen-Shi, Ryu, Min-Hee, Park, Se-Hoon, Chu, Kent-Man, Choo, Su-Pin, Sanchez, Teresa, DelaCruz, Christine, Mukhopadhyay, Pralay, Lainas, Ioannis, Li, Chung-Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456918/
https://www.ncbi.nlm.nih.gov/pubmed/22886073
http://dx.doi.org/10.1007/s00280-012-1943-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456918/
https://www.ncbi.nlm.nih.gov/pubmed/22886073
http://dx.doi.org/10.1007/s00280-012-1943-6

Ejemplares similares